Perrigo Takes Two Steps Forward: Generic Allegra Launch, Manufacturing Compliance
This article was originally published in The Tan Sheet
Executive Summary
Perrigo stokes momentum behind already healthy sales growth with significant steps in separate areas: a green light for regulatory compliance at its main manufacturing plant, and the launch of its generic OTC versions of Sanofi-Aventis' Allegra.
You may also be interested in...
Perrigo Applies Crime Scene Investigation Model To Improve Quality Control
Perrigo quality control managers emphasize immediate investigations of low-risk incidents and forward-looking remediation in the firm’s new corrective and preventive actions strategy.
Perrigo Applies Crime Scene Investigation Model to Improve Quality Control
Perrigo quality control managers emphasize immediate investigations of low-risk incidents and forward-looking remediation in the firm’s new corrective and preventive actions strategy.
Perrigo To Launch Private Label Mucinex, Prevacid, With An Eye On Lipitor
Private label giant Perrigo is readying generic competitors to Reckitt Benckiser’s Mucinex and Takeda Pharmaceuticals’ Prevacid, CEO Joseph Papa says.